Linjing An

878 total citations
19 papers, 607 citations indexed

About

Linjing An is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Linjing An has authored 19 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 12 papers in Epidemiology and 4 papers in Cancer Research. Recurrent topics in Linjing An's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (7 papers). Linjing An is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (7 papers). Linjing An collaborates with scholars based in China and United States. Linjing An's co-authors include Yongping Yang, Yinying Lu, Chunping Wang, Jianhui Qu, Wenlin Bai, Xiujuan Chang, Xudong Gao, Zhen Zeng, Min Lou and Ke‐Qin Hu and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Ethnopharmacology.

In The Last Decade

Linjing An

19 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linjing An China 11 391 229 131 111 102 19 607
Bin-yong Liang China 15 291 0.7× 178 0.8× 154 1.2× 253 2.3× 90 0.9× 32 656
Hiroyuki Fuke Japan 14 299 0.8× 225 1.0× 110 0.8× 274 2.5× 70 0.7× 38 746
Yong‐Fa Zhang China 17 397 1.0× 194 0.8× 160 1.2× 158 1.4× 87 0.9× 32 654
Renay L. Bauer United States 11 318 0.8× 230 1.0× 93 0.7× 269 2.4× 50 0.5× 12 652
Diyang Xie China 8 436 1.1× 215 0.9× 150 1.1× 106 1.0× 109 1.1× 10 632
Osakuni Morimoto Japan 11 484 1.2× 288 1.3× 190 1.5× 105 0.9× 93 0.9× 44 738
Reiichiro Kondo Japan 12 198 0.5× 176 0.8× 180 1.4× 111 1.0× 70 0.7× 42 562
Masaharu Tada Japan 9 331 0.8× 235 1.0× 214 1.6× 160 1.4× 100 1.0× 18 681
Jinzhou Wang China 10 566 1.4× 411 1.8× 164 1.3× 203 1.8× 101 1.0× 16 911
Tenyu Motoyama Japan 14 487 1.2× 295 1.3× 126 1.0× 182 1.6× 92 0.9× 29 744

Countries citing papers authored by Linjing An

Since Specialization
Citations

This map shows the geographic impact of Linjing An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linjing An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linjing An more than expected).

Fields of papers citing papers by Linjing An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linjing An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linjing An. The network helps show where Linjing An may publish in the future.

Co-authorship network of co-authors of Linjing An

This figure shows the co-authorship network connecting the top 25 collaborators of Linjing An. A scholar is included among the top collaborators of Linjing An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linjing An. Linjing An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chen, Yan, Guanglin Lei, Linjing An, et al.. (2023). Serum Exosome–Derived microRNA-193a-5p and miR-381-3p Regulate Adenosine 5'-Monophosphate–Activated Protein Kinase/Transforming Growth Factor Beta/Smad2/3 Signaling Pathway and Promote Fibrogenesis. Clinical and Translational Gastroenterology. 15(2). e00662–e00662. 1 indexed citations
2.
He, Huan, et al.. (2022). Jatrorrhizine from Rhizoma Coptidis exerts an anti-obesity effect in db/db mice. Journal of Ethnopharmacology. 298. 115529–115529. 11 indexed citations
3.
4.
Zheng, Dong, Hui Xie, Wei Zhang, et al.. (2022). Efficacy and safety of percutaneous cryoablation for elderly patients with small hepatocellular carcinoma: A prospective multicenter study. Liver International. 42(4). 918–929. 7 indexed citations
5.
Zhang, Wei, Xiujuan Chang, Linjing An, et al.. (2021). Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus‐Associated Hepatocellular Carcinoma. BioMed Research International. 2021(1). 1093702–1093702. 10 indexed citations
6.
Feng, Fan, Xudong Gao, Chunping Wang, et al.. (2015). MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells. Current Cancer Drug Targets. 15(3). 176–187. 40 indexed citations
7.
Rong, Guanghua, Wenlin Bai, Dong Zheng, et al.. (2015). Long-Term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan Criteria. PLoS ONE. 10(4). e0123065–e0123065. 60 indexed citations
8.
Rong, Guanghua, Hong Wang, Christopher L. Bowlus, et al.. (2015). Incidence and Risk Factors for Hepatocellular Carcinoma in Primary Biliary Cirrhosis. Clinical Reviews in Allergy & Immunology. 48(2-3). 132–141. 48 indexed citations
9.
Rong, Guanghua, Wenlin Bai, Dong Zheng, et al.. (2014). Cryotherapy for cirrhosis-based hepatocellular carcinoma: a single center experience from 1595 treated cases. Frontiers of Medicine. 9(1). 63–71. 9 indexed citations
10.
Wang, Chunping, Huaming Wang, Wuwei Yang, et al.. (2014). Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 61(5). 1579–1590. 185 indexed citations
11.
Yang, Yongping, Jianhui Qu, Xiujuan Chang, et al.. (2013). High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. Journal of Translational Medicine. 11(1). 41–41. 35 indexed citations
12.
Gao, Xudong, Jianhui Qu, Xiujuan Chang, et al.. (2013). Hypomethylation of long interspersed nuclear element‐1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma. Liver International. 34(1). 136–146. 38 indexed citations
13.
Yang, Yongping, Yinying Lu, Chunping Wang, et al.. (2012). Cryotherapy is Associated with Improved Clinical Outcomes of Sorafenib Therapy for Advanced Hepatocellular Carcinoma. Cell Biochemistry and Biophysics. 63(2). 159–169. 23 indexed citations
14.
Wang, Chunping, Yinying Lu, Hong Wang, et al.. (2012). Transarterial chemoembolization with/without cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma. Experimental and Therapeutic Medicine. 4(2). 188–196. 5 indexed citations
15.
Yang, Yongping, Yinying Lu, Chunping Wang, et al.. (2011). Cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma. Experimental and Therapeutic Medicine. 3(2). 171–180. 8 indexed citations
16.
Yang, Yongping, Chunping Wang, Yinying Lu, et al.. (2011). Outcomes of ultrasound‐guided percutaneous argon‐helium cryoablation of hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences. 19(6). 674–684. 51 indexed citations
17.
Chang, Xiujuan, Yinying Lu, Wenlin Bai, et al.. (2011). [Clinical efficacy and prognostic factors for cryoablation patients with advanced hepatocellular carcinoma].. PubMed. 19(10). 759–63. 2 indexed citations
18.
Zhou, Lin, Junliang Fu, Yinying Lu, et al.. (2010). Regulatory T cells are associated with post-cryoablation prognosis in patients with hepatitis B virus-related hepatocellular carcinoma. Journal of Gastroenterology. 45(9). 968–978. 41 indexed citations
19.
Wang, Chunping, Yinying Lu, Yan Chen, et al.. (2009). Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study. Clinical & Experimental Metastasis. 26(7). 839–848. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin-yong Liang Breakdown of academic impact, for papers by Hiroyuki Fuke Breakdown of academic impact, for papers by Yong‐Fa Zhang Breakdown of academic impact, for papers by Renay L. Bauer Breakdown of academic impact, for papers by Diyang Xie Breakdown of academic impact, for papers by Osakuni Morimoto Breakdown of academic impact, for papers by Reiichiro Kondo Breakdown of academic impact, for papers by Masaharu Tada Breakdown of academic impact, for papers by Jinzhou Wang Breakdown of academic impact, for papers by Tenyu Motoyama
Rankless by CCL
2026